135 related articles for article (PubMed ID: 35706508)
41. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
42. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
43. MYC-activated CERS6-AS1 sponges miR-6838-5p and regulates the expression of RUBCNL in colorectal cancer.
Chen D; You H; Xu X; Liu D; Shen M; Pan Y; Liu Z; Zhang L; Wang H
Cell Mol Biol (Noisy-le-grand); 2022 Dec; 68(12):42-48. PubMed ID: 37130182
[TBL] [Abstract][Full Text] [Related]
44. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
45. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
46. [HNF1A-AS1 inhibits proliferation, migration and invasion of IL-6-induced hemangioma endothelial cells by targeting miR-363-3p].
Xu W; Tao S; Zhu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1091-1096. PubMed ID: 34729750
[TBL] [Abstract][Full Text] [Related]
47. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
48. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis.
Wei P; Yang J; Zhang D; Cui M; Li L
Onco Targets Ther; 2020; 13():4523-4531. PubMed ID: 32547083
[TBL] [Abstract][Full Text] [Related]
49. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
50. Effects of IncRNA PROX1-AS1 on Proliferation, Migration, Invasion and Apoptosis of Lung Cancer Cells by Regulating MiR-1305.
Zhao Q; Zhang B; Li Z; Tang W; Du L; Sang H
J Healthc Eng; 2022; 2022():9570900. PubMed ID: 35281529
[TBL] [Abstract][Full Text] [Related]
51. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
[No Abstract] [Full Text] [Related]
52. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
Cao X; Luan K; Yang J; Huang Y
Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
54. Retracted Article: Long noncoding RNA PTPRG-AS1 regulates growth of glioma cells by sponging miR-185-5p.
Xu C; Li Z; He T; Yuan B; Ding B
RSC Adv; 2019 Apr; 9(19):10870-10880. PubMed ID: 35515299
[TBL] [Abstract][Full Text] [Related]
55. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
56. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis.
Zhang L; Xie H; Li S
J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705
[TBL] [Abstract][Full Text] [Related]
57. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
Miao S; Wang J; Xuan L; Liu X
Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
[TBL] [Abstract][Full Text] [Related]
58. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
59. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
[TBL] [Abstract][Full Text] [Related]
60. LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p.
Wang D; Wang Z; Zhang L; Sun S
Transl Oncol; 2021 Jan; 14(1):100958. PubMed ID: 33248413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
